• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The crystalline dihydrate and trihydrate forms of the antibiotic 7 beta -[2 min -(R)-2 min -phenyl-2 min -aminoacetamido]-3-chloro-3-(1-carbadethiacep hem)-4-carboxylic acid ("LY163892") are described. These hydrates are antibiotics in their own right, and are valuable intermediates to the corresponding monohydrate form of LY163892.
    公开号:SU1757468A3
    申请号:SU894742389
    申请日:1989-11-13
    公开日:1992-08-23
    发明作者:Майкл Экрич Томас；Илейн Пасини Кэрол
    申请人:Эли Лилли Энд Компани (Фирма)；
    IPC主号:
    专利说明:

    The invention relates to a method of pol- Used designation: LY teachings of a new crystalline form of anti- 163892 — anhydrous form of compound I. Biotics of the cephalosporin series, namely PRI me R. A) Synthesis of mono-Ν, Ν'-dimecrystalline dihydrate of 1-carbacephyltilformamide solvate LY 163892. losporin of the formula / To a solution of 30 g (0.126 mol) 7 β-aminoK solution of 30 g (0.126 mol) 7/3-amino3-flora About 3 drops of trimethylsilyl chloride, followed by the addition of 32.85 g of M, Lp-bis (trimethylsilyl) urea, -3- (1 -carba-1-child-acepham) -4-carboxylic acid in 500 ml of DMF containing 0.03% water. ; The reaction mixture + - was stirred for 90 minutes at room temperature and cooled to about -50 ° C. To this mixture was added 10.8 ml of pyridine, followed by a higher stability of 27.07 g (0.1315 mol) hydrochloride 2 in conditions of relative humidity. (P -) - 2-phenyl-2-aminoacetyl chloride. The mixture is stirred at a temperature of about -35 ° C
    about
    C1 soon
    1757468 AZ which is used in medicine. The purpose of the invention is the creation of a new crystalline form of cephalosporin, for about 1 h and cooled to -50 ° C. To the mixture was added 7.32 ml of methanol in 30 ml of DMR.
    The reaction mixture was stirred until the temperature became 0 ° C. for 40 minutes and 54 ml of water was added. Over the next 30 minutes the reaction mixture was heated to 15 ° C. and triethylamine was slowly added until the pH of the mixture was established about 3.2, the filtrate is heated to about 50 ° C. Triethylamine is added to the mixture until the pH reaches 4.6, after which the mixture is allowed to remain at room temperature for 1 hour. Then the mixture is stirred at a temperature of about 40 ° C and add a mixture of DMR triethylamine (1: 1 by volume) to those x until pH reaches about 5.9. The mixture was cooled to 25 ° C and stirred for 20 minutes. 50 ml of acetonitrile was added to the mixture, and the resulting mixture was stirred for 30 minutes. The mixture is filtered, and the resulting solid precipitate is dried in air to constant weight at 30 ° C. Get mono-M.H. dimethylformamide solvate LY 163892.
    B) Synthesis of dihydrate L.Y 163892,
    The mono-Ν, Ν-dimethylformamide solvate LY 163892 (79.83 g) is suspended in water (435 ml). Concentrated hydrochloric acid (54.5 ml) of ethylenediaminetetraacetic acid tetrasodium salt (2.18 g) was added to the suspension. The suspension is stirred for 15 minutes at room temperature until a solution is obtained. Charcoal is added to the solution and the resulting suspension is filtered.
    The filter cake was washed with distilled water (200 ml). The pH of the combined filtrate and wash water was adjusted to a value of 2.4 by adding triethylamine, seeded with the solution, crystals of dihydrate LY 163892. The resulting suspension was stirred for 30 minutes. Then the pH of the suspensions was adjusted to 3.6 over 45 minutes by adding triethylamine. The suspension was stirred for 5 hours, cooled to 10 ° C, and then filtered. The filter cake was dried open at room temperature. The dried filter cake was stirred with water (300 ml) and filtered,
    The filter cake was washed with acetonitrile (400 ml). The filter cake is dried open at room temperature, ’. having obtained the yield of crystalline dihydrate LY 163892 26.63,
    权利要求:
    Claims (1)
    [1]
    Claim
    A method of producing crystalline 1-carbacephalosporin dihydrate of the formula I having the following x-ray diffraction properties measured for a powder when irradiated with a wavelength of β = 1.5418 A on a copper tube with a nickel filter (Cu: ΝΙ) with the following values of interplanar spacings d and relative intensities I / I 1 : Interplanar distances Relative
    d 1 1/1 1 16.35 1.00 9.82 0.05 9.50 0.05 8.18 0.90 6.46 0.01 6.32 . 0.04 5.40 0.02 4.72 0.11 4.48 0.04 4.07 0.19 3.88 0.02 3.78 0,07 3.60 0.08 3.45 0.04 3.31 0.01 3.24 0.05 3.10 0.02 2.99 0.05 2.92 0.05
    characterized in that the μοηο-Ν, Ν 1 -αη methylformamide solvate of compound I is dissolved in water, the pH is adjusted to 3.6, followed by filtering the crystals and drying in air at room temperature.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1757468A3|1992-08-23|Method for preparation of crystalline 1-carbocephalosporine-2-water
    DE2718741C2|1985-03-21|Crystalline cefadroxil monohydrate, process for its preparation and pharmaceutical agent
    SU1391499A3|1988-04-23|Method of producing derivative of 1,4-dihydropyridine
    SU654171A3|1979-03-25|Method of obtaining 7-d-/-/a-amino-a-/p-oxyphenylacetamido/-desacetoxycephalosporanic acid or its hydrate or its salt
    AT389876B|1990-02-12|METHOD FOR PRODUCING A CRYSTALLINE DIMETHYLFORMAMIDE SOLVATE OF THE 7 - | -2-AMINO2- | -ACETAMIDO) -3 - | -1PROPENYL) -CEPH-3-EM-4-CARBONS | URE
    EP0129846B1|1991-05-08|methanones
    SU1731058A3|1992-04-30|Antibiotic based on crystalline monohydrate form of 1-carbocephalosporin
    US5412094A|1995-05-02|Bicyclic beta-lactam/paraben complexes
    KR960002910B1|1996-02-28|Method for preparing crystalline cefadroxil monohydrate
    US4525587A|1985-06-25|Process for preparing a cephalosporin compound
    DE2462383A1|1976-12-02|PROCESS FOR MANUFACTURING ANTIBIOTIC AGENTS
    AT392643B|1991-05-10|METHOD FOR PRODUCING NEW DERIVATIVES OF 7- | -ACETAMIDO) -3- | -1-PROPENYL) CEPH-3-EM-4-CARBONIC ACID
    US6001996A|1999-12-14|Complexes of cephalosporins and carbacephalosporins with parabens
    RU2002749C1|1993-11-15|Method for preparing crystal bis-|-1-carbocephalosporin hydrate
    SU1595340A3|1990-09-23|Method of producing dehydrated crystalline cephadroxyl
    PL99979B1|1978-08-31|METHOD OF MAKING NEW THIAZOLIDINAZETIDINONES
    DD201588A5|1983-07-27|PROCESS FOR PREPARING 1-CYANOMETHYL-1H-TETRAZOL-5-THIOL
    SU1095879A3|1984-05-30|Process for preparing derivatives of cephalosporin or their pharmaceutically acceptable salts
    SU1205768A3|1986-01-15|Method of producing 2-guanidine-4-thiazolthiazole derivatives or their acid-additive pharmaceutically acceptable salts
    US4272454A|1981-06-09|Process for the chlorination of α-aminoacids
    SU644385A3|1979-01-25|Method of obtaining 1,5/6/-disubstituted benzimidazole-2-carbamate derivatives or salts thereof
    RU1287510C|1995-06-27|Method of obtaining 5-amino-2-|pyrimidine
    SU448716A1|1979-02-05|Method of producing symm.-triazine derivatives
    JP2662414B2|1997-10-15|Thiazole derivatives
    EP0463553A1|1992-01-02|Cephalosporin derivative
    同族专利:
    公开号 | 公开日
    KR900007840A|1990-06-02|
    NZ231368A|1990-12-21|
    ZA898611B|1991-07-31|
    EP0369686A1|1990-05-23|
    CA2002596A1|1990-05-14|
    PT92275A|1990-05-31|
    DK563789D0|1989-11-10|
    CN1042712A|1990-06-06|
    IL92271D0|1990-07-26|
    DK563789A|1990-05-15|
    HU205113B|1992-03-30|
    HUT52508A|1990-07-28|
    JPH02178281A|1990-07-11|
    AU620659B2|1992-02-20|
    AU4457089A|1990-05-31|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    NO155548C|1979-02-10|1987-04-15|Kyowa Hakko Kogyo Kk|PROCEDURE FOR THE PREPARATION OF OPTICALLY ACTIVE CEPHALOSPORIN ANALOGS.|
    DD273634A5|1987-10-06|1989-11-22|����@�����@�����@����k��|PROCESS FOR PREPARING A CRYSTALLINE MONOHYDRATE OF A 1-CARBACEPHALOSPORIN|
    SU1750429A3|1988-02-05|1992-07-23|Эли Лилли Энд Компани |Method of preparing crystalline 2,5-hydrate-1- carbocephalosporine|
    CA2002597C|1988-11-14|1999-03-23|Thomas M. Eckrich|Solvates of b-lactam antibiotic|CA2002597C|1988-11-14|1999-03-23|Thomas M. Eckrich|Solvates of b-lactam antibiotic|
    CA2034592C|1990-01-26|2001-06-05|Ralph R. Pfeiffer|Crystalline hydrochloride of new beta-lactam antibiotic and process therefor|
    US5399686A|1993-06-04|1995-03-21|Eli Lilly And Company|Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate|
    US5374719A|1993-06-04|1994-12-20|Eli Lilly And Company|Process for converting loracarbef dihydrate to loracarbef monohydrate|
    US5352782A|1993-06-04|1994-10-04|Eli Lilly And Company|Process for preparing crystalline β-lactam monohydrate|
    US5550231A|1993-06-15|1996-08-27|Eli Lilly And Company|Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof|
    US5412094A|1993-06-28|1995-05-02|Eli Lilly And Company|Bicyclic beta-lactam/paraben complexes|
    US5580977A|1995-03-01|1996-12-03|Eli Lilly And Company|Process for preparing loracarbef monohydrate|
    US6001996A|1995-05-11|1999-12-14|Eli Lilly And Company|Complexes of cephalosporins and carbacephalosporins with parabens|
    ZA978515B|1996-09-23|1999-03-23|Lilly Co Eli|Intermediates and process for preparing olanzapine|
    CA2506872A1|2002-11-21|2004-06-03|Ranbaxy Laboratories Limited|Monohydrate solvates of loracarbef|
    AT406364T|2003-03-07|2008-09-15|Schering Corp|SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF HYPERCHOLESTEROLMIA|
    WO2004081003A1|2003-03-07|2004-09-23|Schering Corporation|Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US27179488A| true| 1988-11-14|1988-11-14|
    [返回顶部]